FI941986A7 - Antifungaaliset tri-substituoidut tetrahydrofuraanit - Google Patents

Antifungaaliset tri-substituoidut tetrahydrofuraanit Download PDF

Info

Publication number
FI941986A7
FI941986A7 FI941986A FI941986A FI941986A7 FI 941986 A7 FI941986 A7 FI 941986A7 FI 941986 A FI941986 A FI 941986A FI 941986 A FI941986 A FI 941986A FI 941986 A7 FI941986 A7 FI 941986A7
Authority
FI
Finland
Prior art keywords
antifungal
tri
substituted tetrahydrofurans
tetrahydrofurans
substituted
Prior art date
Application number
FI941986A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI941986A0 (fi
Inventor
Anil K Saksena
Viyyoor M Girijavallabhan
Ashit K Ganguly
Raymond G Lovey
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI941986A0 publication Critical patent/FI941986A0/fi
Publication of FI941986A7 publication Critical patent/FI941986A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI941986A 1991-10-30 1994-04-29 Antifungaaliset tri-substituoidut tetrahydrofuraanit FI941986A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78535791A 1991-10-30 1991-10-30
US90726292A 1992-07-01 1992-07-01
PCT/US1992/008981 WO1993009114A1 (en) 1991-10-30 1992-10-28 Tri-substituted tetrahydrofuran antifungals

Publications (2)

Publication Number Publication Date
FI941986A0 FI941986A0 (fi) 1994-04-29
FI941986A7 true FI941986A7 (fi) 1994-04-29

Family

ID=27120397

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941986A FI941986A7 (fi) 1991-10-30 1994-04-29 Antifungaaliset tri-substituoidut tetrahydrofuraanit

Country Status (22)

Country Link
EP (2) EP0539938A1 (enExample)
JP (1) JP3210017B2 (enExample)
CN (1) CN1037267C (enExample)
AT (1) ATE198888T1 (enExample)
AU (1) AU665218B2 (enExample)
CA (1) CA2122270C (enExample)
CZ (1) CZ102794A3 (enExample)
DE (1) DE69231661T2 (enExample)
ES (1) ES2153364T3 (enExample)
FI (1) FI941986A7 (enExample)
HR (1) HRP921145A2 (enExample)
HU (1) HUT70742A (enExample)
IL (1) IL103558A0 (enExample)
MX (1) MX9206222A (enExample)
MY (1) MY109529A (enExample)
NO (1) NO941589L (enExample)
NZ (1) NZ244910A (enExample)
SG (1) SG42920A1 (enExample)
SI (1) SI9200285A (enExample)
SK (1) SK48894A3 (enExample)
WO (1) WO1993009114A1 (enExample)
YU (1) YU94792A (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403937A (en) * 1993-04-30 1995-04-04 Schering Corporation Process for preparing intermediates for the synthesis of antifungal agents
US5349099A (en) * 1993-12-13 1994-09-20 Schering Corporation Process for preparing intermediates for the synthesis of antifungal agents
HU225062B1 (en) * 1993-12-21 2006-05-29 Schering Corp Tetrahydrofuran derivatives with antifungal- effect, pharmaceutical compositions containing them and process for their preparation
US5703236A (en) * 1993-12-21 1997-12-30 Schering Corporation Tetrahydrofuran antifungals
US5714490A (en) * 1993-12-21 1998-02-03 Schering Corporation Tetrahydrofuran antifungals
US5693626A (en) * 1993-12-21 1997-12-02 Schering Corporation Tetrahydrofuran antifungals
US5661151A (en) * 1993-12-21 1997-08-26 Schering Corporation Tetrahydrofuran antifungals
US5703079A (en) * 1993-12-21 1997-12-30 Schering Corporation Tetrahydrofuran antifungals
US5710154A (en) * 1993-12-21 1998-01-20 Schering Corporation Tetrahydrofuran antifungals
KR100352147B1 (ko) * 1994-01-24 2002-11-11 얀센 파마슈티카 엔.브이. 수용성아졸항진균제
WO1995028374A1 (en) * 1994-04-19 1995-10-26 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for producing triazole derivative
US5442093A (en) * 1994-05-09 1995-08-15 Schering Corporation Process for preparing intermediates for the synthesis of antifungal agents
US5486625A (en) * 1994-07-08 1996-01-23 Schering Corporation Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents
EP0725146A4 (en) * 1994-07-18 1998-12-23 Daicel Chem METHOD FOR PRODUCING OPTICALLY ACTIVE TRIAZOLE COMPOUNDS AND METHOD FOR RAZEMIZING OPTICALLY ACTIVE TRIAZOLE COMPOUNDS
US5625064A (en) * 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
US5616777A (en) * 1995-04-19 1997-04-01 Schering Corporation Chiral hydrazine derivatives
CZ59497A3 (en) * 1995-06-02 1997-08-13 Schering Corp Tetrahydrofuran derivative and pharmaceutical composition containing thereof
US5698557A (en) * 1995-06-19 1997-12-16 Schering Corporation Hydroxy-substituted antifungals
ES2203707T3 (es) * 1995-06-19 2004-04-16 Schering Corporation Antifungicos de tetrahidrofurano.
US5834472A (en) * 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
US5846971A (en) * 1996-06-28 1998-12-08 Schering Corporation Oral antifungal composition
TW593312B (en) 1997-07-11 2004-06-21 Janssen Pharmaceutica Nv 2,4,4-trisubstituted-1,3-dioxolane antifungals
NZ503662A (en) * 1997-10-07 2002-10-25 Schering Corp Crystalline polymorph of (-)-4-[4-[4-[4-[[(2R-cis)-5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)furan-3-yl]-methoxy]phenyl]-1-piperazinyl]phenyl-2,4-dihydro-2-[(S)-1-ethyl-2(S)-hydroxylpropyl]-3H-1,2,4-triazol-3-one and its use as a fungicide
CN1628119A (zh) * 2002-04-12 2005-06-15 兰贝克赛实验室有限公司 作为抗真菌剂的2,2,4-三取代的四氢呋喃衍生物
CN102892762B (zh) 2010-05-19 2016-04-20 桑多斯股份公司 制备泊沙康唑中间体
MX2012013331A (es) 2010-05-19 2013-02-01 Sandoz Ag Purificacion de posaconazol y de intermediarios de posaconazol.
BR112012029225B1 (pt) 2010-05-19 2020-10-27 Sandoz Ag processo para a preparação de um composto quiral, composto quiral e uso de um composto quiral
BR112012029227B1 (pt) 2010-05-19 2020-01-07 Sandoz Ag Processo para a preparação de um composto quiral, composto quiral e uso de um composto
CA2838051C (en) 2011-06-16 2019-09-24 Sandoz Ag Process for the preparation of a chiral compound
CA2913634C (en) * 2013-06-07 2022-08-09 The California Institute For Biomedical Research Small molecule inhibitors of fibrosis
CN106397417A (zh) * 2016-08-30 2017-02-15 甘肃皓天化学科技有限公司 用于制备泊沙康唑的中间体的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4619931A (en) * 1983-02-28 1986-10-28 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles
DE3346123A1 (de) 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
DK354185A (da) 1984-08-31 1986-03-01 Hoffmann La Roche 1,3-dioxolanderivater
NZ223799A (en) * 1987-03-25 1989-12-21 Janssen Pharmaceutica Nv Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions
US5006513A (en) 1987-11-09 1991-04-09 Miles Inc. Antimycotic compositions of nikkomycin compounds and azole antimycotica
EP0318214B1 (en) 1987-11-20 1994-12-14 Schering Corporation Tri- and tetra-substituted-oxetanes and -tetrahydrofurans and intermediates thereof
US5002935A (en) 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
NZ233502A (en) * 1989-06-09 1991-11-26 Janssen Pharmaceutica Nv 4-(1,2,4-triazole- or imidazole-phenyl-substituted) -1-(1,3-dioxolan-4-ylmethoxyphenyl) piperazine derivatives; preparatory processes: fungicidal and antiviral compositions
US5039676A (en) 1990-05-11 1991-08-13 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
US20040220100A1 (en) 2000-07-21 2004-11-04 Essentia Biosystems, Inc. Multi-component biological transport systems

Also Published As

Publication number Publication date
AU2916992A (en) 1993-06-07
HU9401256D0 (en) 1994-08-29
FI941986A0 (fi) 1994-04-29
NO941589L (enExample) 1994-06-23
MY109529A (en) 1997-02-28
CA2122270C (en) 2006-05-23
SG42920A1 (en) 1997-10-17
NO941589D0 (enExample) 1994-04-29
WO1993009114A1 (en) 1993-05-13
JPH07500605A (ja) 1995-01-19
NZ244910A (en) 1996-01-26
EP0539938A1 (en) 1993-05-05
EP0610377A1 (en) 1994-08-17
SK48894A3 (en) 1995-02-08
AU665218B2 (en) 1995-12-21
EP0610377B1 (en) 2001-01-24
MX9206222A (es) 1993-04-01
YU94792A (sh) 1995-12-04
CN1073944A (zh) 1993-07-07
IL103558A0 (en) 1993-03-15
ES2153364T3 (es) 2001-03-01
ATE198888T1 (de) 2001-02-15
HRP921145A2 (en) 1994-08-31
CZ102794A3 (en) 1995-03-15
CA2122270A1 (en) 1993-05-13
JP3210017B2 (ja) 2001-09-17
SI9200285A (en) 1993-06-30
HUT70742A (en) 1995-10-30
DE69231661D1 (de) 2001-03-01
CN1037267C (zh) 1998-02-04
DE69231661T2 (de) 2001-08-02

Similar Documents

Publication Publication Date Title
FI941986A7 (fi) Antifungaaliset tri-substituoidut tetrahydrofuraanit
FI962577L (fi) Antifungaaliset tetrahydrofuraanit
DE69217997D1 (de) Pyrazolcarboxamilide als fungizide
FI935134A7 (fi) Substituoidut 3-aminokinuklidiinit
FI925100A7 (fi) Substituoituja bifenyylipyridoneja
FI933655L (fi) Reducerad polydextros
FI935880A7 (fi) Immobiliserade lewis-syrakatalysatorer
DE69232341D1 (de) Bewegungskompensationsvorrichtung
KR920018690U (ko) 전동안테나 장치
FI941644L (fi) Sieniä vastustavat triatsoliyhdisteet
DE69223533D1 (de) Kodierer
FI934441A0 (fi) Antifungal mikroorganism
FI933062L (fi) Vedklyv
NO924745D0 (no) Benzofuraner
ITMN910019V0 (it) Tappo antiprofanazione
ITMI911812A0 (it) Benzofenoni ad azione antifungina
NO921942L (no) Benzofuranderivater
TR25953A (tr) SüBSTITüE EDILMIS 2-ARILPIROLLER
DE4294912T1 (de) Balkonanordnung
KR930006731U (ko) 스팡글 띠
FI940934A7 (fi) Vaahdonestokoostumus
TR26694A (tr) SüBSTITüE EDILMIS 4-HETARIL-PIRAZOLINLER
ITTO920010A1 (it) Incannatoio
NO934382D0 (no) Suppressor T-celle - hybridoma
FI920903A7 (fi) Stroemdetektor enligt kompensationsprincipen

Legal Events

Date Code Title Description
FD Application lapsed